Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 18.59% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTCryoport, Inc.'s latest supported as-filed period reports revenue of $49.0M; gross margin moved 42 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 18.59% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 2.31% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 7.74% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 43.92% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 46.61% · CORE
Level · gp.fundamentals.operating_margin
Raw value -20.50% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +10.6% from the comparable as-filed period.
Gross margin changed -42 basis points from the comparable as-filed period.
Gross profit changed +6.8% from the comparable as-filed period.
Inventory changed -6.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CYRX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-094228SEC ↗10-QAug 6, 2026Period Jun 30, 20260001104659-26-092107SEC ↗8-KAug 6, 2026Period Aug 6, 20260001104659-26-092064SEC ↗4Jun 12, 2026Period Jun 10, 20260001104659-26-073630SEC ↗8-KJun 9, 2026Period Jun 5, 20260001104659-26-071892SEC ↗4Jun 9, 2026Period Jun 5, 20260001104659-26-071724SEC ↗4Jun 8, 2026Period Jun 4, 20260001104659-26-071509SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 11, 2026Filed Aug 11, 2026 | SHELTON JERRELLPresident, CEO | Open Market SaleDirect | 28,800 | $15 | $429,385 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 9.91% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 4.90% · OPTIONAL
Net income changed -107.8% from the comparable as-filed period.
Operating income changed -4.0% from the comparable as-filed period.
Operating margin changed +73 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-071508